ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
InfuSystem to Participate in Lake Street’s 6th Annual Best Ideas Growth (BIG6) Conference September 14, 2022
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
InfuSystem Reports Second Quarter 2022 Financial Results
Net Revenues increased 9% to $27 million; ITS revenues increased 6% and DME revenues increased 15% ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating...
InfuSystem to Report Second Quarter 2022 Financial Results on August 4, 2022
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain Management
The Company will offer Ventis Pharma's patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national...
InfuSystem to Participate at Craig-Hallum 19th Annual Institutional Investor Conference on Wednesday, June 1, 2022
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
InfuSystem Reports First Quarter 2022 Financial Results
Signed 3-year Master Service Agreement with Leading Global Medical Technology and Diagnostic Company - Estimated Potential Annual Revenue of $10 Million to $12 Million Revenue Growth of 9% - Driven by 18% Growth in DME and 5% in ITS Strong Operating Cash Flow Growth...
InfuSystem Announces Master Service Agreement with Leading Global Healthcare Technology and Diagnostic Company
Preferred National Service Agreement to provide service and repair to fleet of more than 300,000 pumps in North America; Estimated $10-$12 million of annual revenue ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the...
InfuSystem to Report First Quarter 2022 Financial Results on May 5, 2022
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block Catheters
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the "Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today...